“Cardiac surgery and interventional cardiology are two major segments that make up the cardiovascular disease (CVD) market. Cardiac surgery is focused on cardiovascular procedures involving the repair or replacement of the heart, its valves, bypassing damages or occluded vessels, and other procedures to improve the functions of the cardiovascular system with a wide variety of devices. Interventional cardiology is focused on minimally invasive treatments for structural and functional heart disease using catheter-based approaches. Generally, these procedures include devices such as catheters, guide wires, and stents and so on.
Stents occupy the dominant share among all the devices used in interventional cardiology worldwide. The technological advances in the field of medicine and surgery have led to inventions such as bio-absorbable or biodegradable stents which are currently largely being used in interventional cardiac surgeries, thereby being one of the primary factors driving the global surgical and interventional cardiology devices market.
The global Cardiology Surgical & Interventional Cardiology market was valued at $XXbn in 2014 and is growing at a CAGR of around XX% through 2020.
The US is the largest market for Cardiology Surgical & Interventional Cardiology devices owing to factors such as high healthcare expenditures, patient awareness levels and sophisticated healthcare infrastructure. On the contrary, APAC is expected to show largest growth in the market owing to the presence of high unmet medical needs mainly coming from China and Japan. The increasing prevalence of cardiovascular diseases is the leading factor driving the market. Other factors contributing to the market growth include aging population, sedentary lifestyle and changing dietary habits, innovations in the field cardiology as well as the rise in number of interventional cardiologists, and increasing demand for minimally invasive surgical techniques.
The global cardiology surgical & interventional cardiology devices market is dominated by stents and the global market for the stents used in cardiovascular operations (coronary stents) has a dominant presence in the U.S. owing to the rapidly aging population in North America. It is followed by the European countries and Japan.”
“1. Global Cardiology Surgical & Interventional Cardiology Devices – Market Overview
2. Executive Summary
3. Global Cardiology Surgical & Interventional Cardiology Devices – Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financials Analysis
4. Global Cardiology Surgical & Interventional Cardiology Devices – Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Global Cardiology Surgical & Interventional Cardiology Devices Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Global Cardiology Surgical & Interventional Cardiology Devices Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Global Cardiology Surgical & Interventional Cardiology Devices Market – By Type of Cardiac Surgery
6.1. Coronary Artery Bypass Grafting (CABG)
6.2. Transmyocardial Laser Revascularization (TMR)
6.3. Heart Valve Repair or Replacement
6.4. Arrhythmia Treatment
6.5. Aneurysm Repair
6.6. Heart Transplant
6.7. Surgery To Place Ventricular Assist Devices or Total Artificial Hearts
7. Global Cardiology Surgical & Interventional Cardiology Devices Market, By Type of Surgical Approach
7.1. Open-Heart Surgery
7.2. Off-Pump Heart Surgery
7.3. Minimally Invasive Heart Surgery
8. Global Cardiology Surgical & Interventional Cardiology Devices Market, By Type of Device
8.1. Cardiovascular Surgical Devices
8.1.1. Beating Heart Surgery System
8.1.2. Cardiac Ablation Devices
8.1.3. Cardiopulmonary Bypass Equipment
8.1.4. Perfusion Disposables
8.2. Interventional Devices
8.2.1. Artereotomy Closure Devices
8.2.2. Cardiac Catheters
8.2.3. Coronary Guidewires
8.2.4. Coronary Stents
8.2.5. Intravascular Ultrasound Systems (IVUS)
8.2.6. Percutaneous Transluminal Coronary Balloons (PTCA)
8.2.7. PTCA Coronary Drug Eluting Balloons
9. Global Cardiology Surgical & Interventional Cardiology Devices Market, By Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. U.K.
9.3.2. France
9.3.3. Germany
9.3.4. Italy
9.3.5. Spain
9.3.6. Others
9.4. APAC
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. Australia
9.4.5. Others
9.5. ROW
10. Global Cardiology Surgical & Interventional Cardiology Devices Market – Market Entropy
10.1. New Product Launches
10.2. M&As, Collaborations, JVs and Partnerships
11. Company Profiles
11.1. Abbott Cardiovascular
11.2. Biosense Webster, Inc.
11.3. Boston Scientific Corporation
11.4. C.R. Bard, Inc.
11.5. Cook Medical
11.6. Covidien
11.7. Edwards Lifescience Corp.
11.8. Johnson & Johnson
11.9. Medtronic. Inc
11.10. Plc Medical Systems
11.11. St. Jude Medical
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
“”*Financials would be provided on a best efforts basis for private companies””
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer
PLEASE SELECT LICENCE
Single User Licence:
US $4250
Corporate User Licence:
US $6250
PROCURE NOW
Request Sample Brochure
Inquiry Before Buying
“
“11.1. Abbott Cardiovascular
11.2. Biosense Webster, Inc.
11.3. Boston Scientific Corporation
11.4. C.R. Bard, Inc.
11.5. Cook Medical
11.6. Covidien
11.7. Edwards Lifescience Corp.
11.8. Johnson & Johnson
11.9. Medtronic. Inc
11.10. Plc Medical Systems
11.11. St. Jude Medical”
